Xinyuan Zhang

机构：Peking University, National Clinical Research Center for Digestive Diseases, Wuxi Vocational Institute of Commerce, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-0315-0392

发表论文 16 篇 · 总被引 294 次 · h-index 9

代表论文

• Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma (2023 · Hepatology International · 被引 60)
• Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (2022 · Frontiers in Immunology · 被引 51)
• Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma (2023 · BMC Cancer · 被引 37)
• Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors (2021 · International Journal of Hyperthermia · 被引 27)
• Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study (2021 · European Journal of Radiology · 被引 24)
• Prognosis and Nomogram Prediction for Patients with Oral Squamous Cell Carcinoma: A Cohort Study (2023 · Diagnostics · 被引 22)